Receptor-mediated gene delivery using bacteriophage vectors
US6054312A · kind A · utility
62Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 1997 |
| Grant date | Apr 25, 2000 |
| Priority date | — |
| Expiry date | Aug 29, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2810/851
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Filamentous phage particles displaying a ligand on their surface are used to deliver a therapeutic gene to a cell. The ligand is a fusion protein with a phage capsid protein, covalently conjugated to phage particles, or complexed with modified phage particles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.